Related Experiment Video
Updated: Oct 18, 2025

Coculture Analysis of Extracellular Protein Interactions Affecting Insulin Secretion by Pancreatic Beta Cells
Published on: June 15, 2013
The Tetracycline-Controlled Transactivator (Tet-On/Off) System in β-Cells Reduces Insulin Expression and Secretion in
Nathalie Jouvet1, Khalil Bouyakdan2, Scott A Campbell2,3
1Institut de recherches cliniques de Montréal (IRCM), Montréal, Quebec, Canada nathalie.jouvet@ircm.qc.ca jennifer.estall@ircm.qc.ca.
Abstract:
Controllable genetic manipulation is an indispensable tool in research, greatly advancing our understanding of cell biology and physiology. However in β-cells, transgene silencing, low inducibility, ectopic expression, and off-targets effects are persistent challenges. In this study, we investigated whether an inducible Tetracycline (Tet)-Off system with β-cell-specific mouse insulin promoter (MIP)-itTA-driven expression of tetracycline operon (TetO)-CreJaw/J could circumvent previous issues of specificity and efficacy. Following assessment of tissue-specific gene recombination, β-cell architecture, in vitro and in vivo glucose-stimulated insulin secretion, and whole-body glucose homeostasis, we discovered that expression of any tetracycline-controlled transactivator (e.g., improved itTA, reverse rtTA, or tTA) in β-cells significantly reduced Insulin gene expression and decreased insulin content. This translated into lower pancreatic insulin levels and reduced insulin secretion in mice carrying any tTA transgene, independent of Cre recombinase expression or doxycycline exposure. Our study echoes ongoing challenges faced by fundamental researchers working with β-cells and highlights the need for consistent and comprehensive controls when using the tetracycline-controlled transactivator systems (Tet-On or Tet-Off) for genome editing.
Insights
Tetracycline-controlled transactivator expression in pancreatic beta cells disrupts insulin gene expression and secretion, regardless of system activation. This highlights challenges in genetic manipulation of beta cells using Tet-On/Tet-Off systems.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Controllable genetic manipulation is crucial for cell biology research.
- Challenges in beta-cell research include transgene silencing and off-target effects.
Purpose of the Study:
- To investigate if a Tetracycline (Tet)-Off system with a beta-cell-specific promoter could improve genetic manipulation in beta cells.
- To assess the impact of Tet-On/Tet-Off systems on beta-cell function and insulin regulation.
Main Methods:
- Utilized a Tet-Off system with mouse insulin promoter (MIP)-driven expression of tetracycline operon (TetO)-Cre in mice.
- Evaluated tissue-specific gene recombination, beta-cell architecture, glucose-stimulated insulin secretion (in vitro and in vivo), and glucose homeostasis.
Main Results:
- Expression of tetracycline-controlled transactivators (tTA, rtTA) in beta cells significantly reduced Insulin gene expression and insulin content.
- Pancreatic insulin levels and insulin secretion were decreased in mice with tTA transgenes, irrespective of Cre or doxycycline.
- Beta-cell function was impaired by the mere presence of the transactivator transgene.
Conclusions:
- The presence of tetracycline-controlled transactivator transgenes in beta cells negatively impacts insulin production and secretion.
- Existing Tet-On and Tet-Off systems present significant challenges for reliable genetic manipulation in beta cells.
- Emphasizes the need for rigorous controls when employing Tet-On/Tet-Off systems in beta-cell research.
Related Concept Videos
Cell Specific Gene Expression
Insulin: The Receptor and Signaling Pathways
Insulin Secretory Vesicles
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

